TSVT - 2seventy bio, Inc.
IEX Last Trade
3.02
-0.030 -0.993%
Share volume: 0
Last Updated: Fri 27 Dec 2024 03:30:20 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-1.15%
PREVIOUS CLOSE
CHG
CHG%
$3.05
-0.03
-0.98%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-10 | 2022-11-07 | 2023-03-16 | 2023-05-10 | 2023-08-14 | 2023-11-14 | 2024-03-07 | 2024-05-09 | |
| Total revenue | 13.482 M | 13.408 M | 56.177 M | 41.621 M | 36.048 M | 12.034 M | 10.684 M | 12.435 M | |
| Cost of revenue | 364.000 K | 377.000 K | 474.000 K | 641.000 K | 907.000 K | 551.000 K | 0.000 | 0.000 | |
| Gross profit | 13.118 M | 13.031 M | 55.703 M | 40.980 M | 35.141 M | 11.483 M | 10.684 M | 12.435 M | |
| -0.66% | 327.47% | -26.43% | -14.25% | -67.32% | -6.96% | 16.39% | |||
| Operating expenses | 85.717 M | 81.349 M | 68.013 M | 88.966 M | 79.469 M | 64.319 M | 67.418 M | 56.590 M | |
| Selling general and admin | 17.278 M | 19.610 M | 18.701 M | 20.720 M | 19.489 M | 13.004 M | 16.201 M | 12.659 M | |
| Research and development | 68.439 M | 61.739 M | 49.312 M | 68.246 M | 59.980 M | 51.315 M | 51.217 M | 43.931 M | |
| Total expenses | 90.371 M | 81.726 M | 83.338 M | 93.261 M | 83.986 M | 69.278 M | 70.565 M | 59.859 M | |
| -9.57% | 1.97% | 11.91% | -9.95% | -17.51% | 1.86% | -15.17% | |||
| Operating income | -76.889 M | -68.318 M | -27.161 M | -51.640 M | -47.938 M | -57.244 M | -59.881 M | -47.424 M | |
| Ebit | -76.889 M | -68.318 M | -27.161 M | -51.640 M | -47.938 M | -57.244 M | -59.881 M | -47.424 M | |
| Pretax income | -77.403 M | -67.879 M | -23.160 M | -47.021 M | -42.089 M | -71.638 M | -56.822 M | -52.673 M | |
| -12.30% | -65.88% | 103.03% | -10.49% | 70.21% | -20.68% | -7.30% | |||
| Income tax | 17.000 K | 0.000 | -17.000 K | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | -77.420 M | -67.879 M | -23.143 M | -47.021 M | -42.089 M | -71.638 M | -56.822 M | -52.673 M | |
| 12.32% | 65.91% | -103.18% | 10.49% | -70.21% | 20.68% | 7.30% | |||
| Net income | -77.420 M | -67.879 M | -23.143 M | -47.021 M | -42.089 M | -71.638 M | -56.822 M | -52.673 M | |
| 12.32% | 65.91% | -103.18% | 10.49% | -70.21% | 20.68% | 7.30% |